BTAI (bioxceltherapeutics.com) Rega marang bathi mangsa ngarep

BioXcel Therapeutics Corp - logo grafis emiten BTAI

The consensus forward P/E of BioXcel Therapeutics (BTAI) illustrates the link between psychiatric centers' demand for agitation treatments and the outsourcing of production to CDMO plants. The current level stands at 0.00, confirming the market valuation of BioXcel Therapeutics assets. Stable raw material inventories and streamlined logistics guarantee sustainable growth of indicators in the future.

BTAI - Rasio prakiraan rega marang bathi BioXcel Therapeutics Inc ing rentang 04.07.2022 - 19.09.2026

Rincian metrik keuangan lan pasar BioXcel Therapeutics Corp (BTAI)

- rega saiki lan proyeksi nilai saham:
Kutipan saham BioXcel Therapeutics, Inc.|BTAI - Konsensus nilai wajar
- indikator valuasi pasar bisnis:
Nilai pasar BioXcel Therapeutics Inc|BTAI - Nilai Bisnis
- data ekuitas miturut neraca:
Nilai Buku saben Saham BioXcel Therapeutics|BTAI - Ekuitas Perusahaan|Rasio Kapitalisasi marang Aset Bersih bioxceltherapeutics.com|BTAI - Total Aset Perusahaan
- rincian struktur utang lan likuiditas bisnis:
Utang marang Ekuitas BioXcel Therapeutics|BTAI - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas BioXcel Therapeutics|BTAI - Utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku BioXcel Therapeutics Inc|BTAI - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan BioXcel Therapeutics|Rasio cepet bioxceltherapeutics.com
- statistik bathi lan rasio pasar:
BTAI - Bathi resik taunan|Bathi mangsa ngarep BioXcel Therapeutics|BTAI - Kapitalisasi marang bathi|Pangali Forward P/E BioXcel|BTAI - Rasio rega marang bathi tumrap wutah|Pangali EV/EBITDA BioXcel Therapeutics Inc|BTAI - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan BioXcel Therapeutics|BTAI - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan bioxceltherapeutics.com|BTAI - Wutah bathi saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep BioXcel Therapeutics
Analisis kabeh metrik perusahaan:BTAI BioXcel Therapeutics, Inc.
Produk mawa merek BioXcel Therapeutics

The forward P/E reflects the ratio of the current share price to projected earnings, allowing for an assessment of market expectations regarding the issuer's profitability for the upcoming period. By analyzing the forward P/E valuation trends of BioXcel Therapeutics (BTAI), an investor can determine the degree of the asset's overvaluation, which is critical for BioXcel Therapeutics, as its market capitalization depends on the effectiveness of implementing AI into the repurposing of psychiatric drugs.

Perusahaan pesaing

Prakiraan rega marang bathi JAZZ (Jazz Pharmaceuticals plc)|CYTK (Cytokinetics Inc.) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep PTC Therapeutics Corp PTCT|SRRK: Rasio rega marang bathi mangsa ngarep|Centessa Pharmaceuticals - Pangali Forward P/E|Rasio prakiraan rega marang bathi dyne-tx.com|EWTX (Edgewise Therapeutics, Inc.) - Prakiraan rega marang bathi|Rapport Therapeutics Inc (RAPP) - Pangali Forward P/E|Rega marang bathi mangsa ngarep Alumis Corp|ZVRA: Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Contineum Therapeutics, Inc. (CTNM)|LRMR - Rasio prakiraan rega marang bathi|Rega marang bathi mangsa ngarep Capricor Therapeutics, Inc. CAPR|Entrada Therapeutics Inc. - Rega marang bathi mangsa ngarep|PTHS - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi MediciNova, Inc.|SER: Pangali Forward P/E|Pangali forward rega marang bathi ProMIS Neurosciences, Inc. PMN|Prakiraan rega marang bathi APUS|Rasio prakiraan rega marang bathi AEON Bio AEON|Pangali Forward P/E NLSP|Rega marang bathi mangsa ngarep BNOX (bionomics.com.au)|Pangali Forward P/E HUGE (FSD Pharma)|Kapitalisasi marang proyeksi bathi reatapharma.com (RETA)